Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $42.32 USD
Change Today +1.07 / 2.59%
Volume 193.4K
OCUL On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Amarpreet Sawhney Ph.D.

Founder, Chairman, Chief Executive Officer and President, Ocular Therapeutix, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 4 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Amarpreet Sawhney, also known as Amar, Ph.D. is Co-Founder and Managing Partner at Incept, LLC. Dr. Sawhney founded Ocular Therapeutix, Inc November 2006 and has been its Chief Executive Officer and President since 2006 and has been its Chairman since June 2014. Dr. Sawhney served as Advisor at Axtria, Inc. Dr. Sawhney served as the President and Chief Executive Officer at Confluent Surgical, Inc. He is the President and Chief Executive Officer at Octux, Inc. Dr. ...

Read Full Background

Corporate Headquarters*

36 Crosby Drive
Bedford, Massachusetts 01730

United States

Phone: 781-357-4000
Fax: 781-357-4001

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director
Former Director
Founder, Chairman, Chief Executive Officer and President


Indian Institute of Technology, Delhi
The University of Texas, Austin
The University of Texas, Austin

Other Affiliations*

Annual Compensation*

Total Annual Compensation$254,894

Stock Options*

Restricted Stock Awards$220,613
Exercisable Options169,166
Unexercisable Options620,834
Total Number of Options790,000

Total Compensation*

Total Annual Cash Compensation$254,894
Total Short Term Compensation$254,894
Other Long Term Compensation$220,613
Total Calculated Compensation$736,134
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCUL:US $42.32 USD +1.07


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULAR THERAPEUTIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at